Lapsi Health's Keikku, a digital stethoscope gaining FDA approval, signifies a shift towards consumer-oriented medical technology, guiding chronic condition monitoring through acoustic and sensor data.
The startup's Keikku aims to transform pediatric asthma detection, while future devices, including a novel wearable for mothers-to-be, enhance fetal monitoring with advanced acoustic processing.
By evolving the stethoscope into a digital platform, Lapsi Health not only modernizes a key medical instrument but also offers functionalities like secure communication and data streaming.
With plans for a second-generation device to launch by late 2025, Lapsi showcases ambitions to expand its sensor technology into a comprehensive health tracking system.
Collection
[
|
...
]